462 related articles for article (PubMed ID: 36571985)
1. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
2. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K
Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117
[TBL] [Abstract][Full Text] [Related]
3. Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
Payne K; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Head Neck; 2022 Nov; 44(11):2545-2554. PubMed ID: 35932094
[TBL] [Abstract][Full Text] [Related]
4. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
5. EMT-related transcription factors and protein stabilization mechanisms involvement in cadherin switch of head and neck squamous cell carcinoma.
Ingruber J; Dudás J; Savic D; Schweigl G; Steinbichler TB; Greier MDC; Santer M; Carollo S; Trajanoski Z; Riechelmann H
Exp Cell Res; 2022 May; 414(1):113084. PubMed ID: 35219646
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro.
Sun Z; Hu W; Xu J; Kaufmann AM; Albers AE
Int J Oncol; 2015 Oct; 47(4):1339-50. PubMed ID: 26323460
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analysis identifies HPV-related tumor microenvironment remodeling prognostic biomarkers in head and neck squamous cell carcinoma.
Zhou Q; Yuan O; Cui H; Hu T; Xiao GG; Wei J; Zhang H; Wu C
Front Cell Infect Microbiol; 2022; 12():1007950. PubMed ID: 36425786
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of epithelial-mesenchymal transition-inducing transcription factors in head and neck squamous cell carcinoma: A meta-analysis.
Wan Y; Liu H; Zhang M; Huang Z; Zhou H; Zhu Y; Tao Y; Xie N; Liu X; Hou J; Wang C
Head Neck; 2020 May; 42(5):1067-1076. PubMed ID: 32048783
[TBL] [Abstract][Full Text] [Related]
10. The Blood Microenvironment Influences the Molecular Phenotypes of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma.
Tada H; Takahashi H; Ida S; Mito I; Matsuyama T; Chikamatsu K
Anticancer Res; 2021 Feb; 41(2):885-893. PubMed ID: 33517294
[TBL] [Abstract][Full Text] [Related]
11. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
[TBL] [Abstract][Full Text] [Related]
12. Immune microenvironment of human papillomavirus-positive head and neck squamous cell carcinoma.
Zhu D; He X; Li Y; Li G; Chen M
Sci Prog; 2024; 107(1):368504241237888. PubMed ID: 38545800
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
Tada H; Takahashi H; Ida S; Nagata Y; Chikamatsu K
Anticancer Res; 2020 Jun; 40(6):3559-3564. PubMed ID: 32487658
[TBL] [Abstract][Full Text] [Related]
14. Expression of immune-regulatory molecules in circulating tumor cells derived from patients with head and neck squamous cell carcinoma.
Chikamatsu K; Tada H; Takahashi H; Kuwabara-Yokobori Y; Ishii H; Ida S; Shino M
Oral Oncol; 2019 Feb; 89():34-39. PubMed ID: 30732956
[TBL] [Abstract][Full Text] [Related]
15. 5'-Ectonucleotidase CD73/NT5E supports EGFR-mediated invasion of HPV-negative head and neck carcinoma cells.
Shi E; Wu Z; Karaoglan BS; Schwenk-Zieger S; Kranz G; Abdul Razak N; Reichel CA; Canis M; Baumeister P; Zeidler R; Gires O
J Biomed Sci; 2023 Aug; 30(1):72. PubMed ID: 37620936
[TBL] [Abstract][Full Text] [Related]
16. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
Li J; Tang LL; Ma J
BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
[TBL] [Abstract][Full Text] [Related]
17. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
[TBL] [Abstract][Full Text] [Related]
18. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
[TBL] [Abstract][Full Text] [Related]
19. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of TWIST2 correlates with poor prognosis in head and neck squamous cell carcinomas.
Gasparotto D; Polesel J; Marzotto A; Colladel R; Piccinin S; Modena P; Grizzo A; Sulfaro S; Serraino D; Barzan L; Doglioni C; Maestro R
Oncotarget; 2011 Dec; 2(12):1165-75. PubMed ID: 22201613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]